カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

世界の性的増強用医薬品市場2022年：市場規模予測（～2028年）

■ 英語タイトル：Global Drugs for Sexual Enhancement Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR22NO19277）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR22NO19277
■ 発行日：2022年11月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：99
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界の性的増強用医薬品市場2022年：市場規模予測（～2028年）]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

性的増強用医薬品市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界の性的増強用医薬品の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

性的増強用医薬品市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・男性性増強剤、女性性増強剤

用途別セグメントは次のように区分されます。
・実店舗、オンラインストア

世界の性的増強用医薬品市場の主要な市場プレーヤーは以下のとおりです。
・Pfizer, Inc.、Leading Edge Health、Innovus Pharmaceuticals、Direct Digital、SizeGenix、TEK Naturals、Vimax、Xanogen、Vydox

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、性的増強用医薬品製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な性的増強用医薬品メーカーの企業概要、2019年～2022年までの性的増強用医薬品の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な性的増強用医薬品メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別性的増強用医薬品の販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までの性的増強用医薬品の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での性的増強用医薬品市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、および性的増強用医薬品の産業チェーンを掲載しています。
・第13、14、15章では、性的増強用医薬品の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- 性的増強用医薬品の概要
- 種類別分析（2017年vs2021年vs2028年）：男性性増強剤、女性性増強剤
- 用途別分析（2017年vs2021年vs2028年）：実店舗、オンラインストア
- 世界の性的増強用医薬品市場規模・予測
- 世界の性的増強用医薬品生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- Pfizer, Inc.、Leading Edge Health、Innovus Pharmaceuticals、Direct Digital、SizeGenix、TEK Naturals、Vimax、Xanogen、Vydox
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：男性性増強剤、女性性増強剤
・用途別分析2017年-2028年：実店舗、オンラインストア
・性的増強用医薬品の北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・性的増強用医薬品のヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・性的増強用医薬品のアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・性的増強用医薬品の南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・性的増強用医薬品の中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Drugs for Sexual Enhancement market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Drugs for Sexual Enhancement market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Physical Stores accounting for % of the Drugs for Sexual Enhancement global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Male Sexual Enhancer segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Drugs for Sexual Enhancement include Pfizer, Inc., Leading Edge Health, Innovus Pharmaceuticals, Direct Digital, and SizeGenix, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Drugs for Sexual Enhancement market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Male Sexual Enhancer
Female Sexual Enhancer
Market segment by Application can be divided into
Physical Stores
Online Stores
The key market players for global Drugs for Sexual Enhancement market are listed below:
Pfizer, Inc.
Leading Edge Health
Innovus Pharmaceuticals
Direct Digital
SizeGenix
TEK Naturals
Vimax
Xanogen
Vydox
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Drugs for Sexual Enhancement product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Drugs for Sexual Enhancement, with price, sales, revenue and global market share of Drugs for Sexual Enhancement from 2019 to 2022.
Chapter 3, the Drugs for Sexual Enhancement competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Drugs for Sexual Enhancement breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Drugs for Sexual Enhancement market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Drugs for Sexual Enhancement.
Chapter 13, 14, and 15, to describe Drugs for Sexual Enhancement sales channel, distributors, customers, research findings and conclusion, appendix and data source.

*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Drugs for Sexual Enhancement Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Drugs for Sexual Enhancement Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Male Sexual Enhancer
1.2.3 Female Sexual Enhancer
1.3 Market Analysis by Application
1.3.1 Overview: Global Drugs for Sexual Enhancement Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Physical Stores
1.3.3 Online Stores
1.4 Global Drugs for Sexual Enhancement Market Size & Forecast
1.4.1 Global Drugs for Sexual Enhancement Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Drugs for Sexual Enhancement Sales in Volume (2017-2028)
1.4.3 Global Drugs for Sexual Enhancement Price (2017-2028)
1.5 Global Drugs for Sexual Enhancement Production Capacity Analysis
1.5.1 Global Drugs for Sexual Enhancement Total Production Capacity (2017-2028)
1.5.2 Global Drugs for Sexual Enhancement Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Drugs for Sexual Enhancement Market Drivers
1.6.2 Drugs for Sexual Enhancement Market Restraints
1.6.3 Drugs for Sexual Enhancement Trends Analysis
2 Manufacturers Profiles
2.1 Pfizer, Inc.
2.1.1 Pfizer, Inc. Details
2.1.2 Pfizer, Inc. Major Business
2.1.3 Pfizer, Inc. Drugs for Sexual Enhancement Product and Services
2.1.4 Pfizer, Inc. Drugs for Sexual Enhancement Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Leading Edge Health
2.2.1 Leading Edge Health Details
2.2.2 Leading Edge Health Major Business
2.2.3 Leading Edge Health Drugs for Sexual Enhancement Product and Services
2.2.4 Leading Edge Health Drugs for Sexual Enhancement Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Innovus Pharmaceuticals
2.3.1 Innovus Pharmaceuticals Details
2.3.2 Innovus Pharmaceuticals Major Business
2.3.3 Innovus Pharmaceuticals Drugs for Sexual Enhancement Product and Services
2.3.4 Innovus Pharmaceuticals Drugs for Sexual Enhancement Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Direct Digital
2.4.1 Direct Digital Details
2.4.2 Direct Digital Major Business
2.4.3 Direct Digital Drugs for Sexual Enhancement Product and Services
2.4.4 Direct Digital Drugs for Sexual Enhancement Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 SizeGenix
2.5.1 SizeGenix Details
2.5.2 SizeGenix Major Business
2.5.3 SizeGenix Drugs for Sexual Enhancement Product and Services
2.5.4 SizeGenix Drugs for Sexual Enhancement Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 TEK Naturals
2.6.1 TEK Naturals Details
2.6.2 TEK Naturals Major Business
2.6.3 TEK Naturals Drugs for Sexual Enhancement Product and Services
2.6.4 TEK Naturals Drugs for Sexual Enhancement Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Vimax
2.7.1 Vimax Details
2.7.2 Vimax Major Business
2.7.3 Vimax Drugs for Sexual Enhancement Product and Services
2.7.4 Vimax Drugs for Sexual Enhancement Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Xanogen
2.8.1 Xanogen Details
2.8.2 Xanogen Major Business
2.8.3 Xanogen Drugs for Sexual Enhancement Product and Services
2.8.4 Xanogen Drugs for Sexual Enhancement Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Vydox
2.9.1 Vydox Details
2.9.2 Vydox Major Business
2.9.3 Vydox Drugs for Sexual Enhancement Product and Services
2.9.4 Vydox Drugs for Sexual Enhancement Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Drugs for Sexual Enhancement Breakdown Data by Manufacturer
3.1 Global Drugs for Sexual Enhancement Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Drugs for Sexual Enhancement Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Drugs for Sexual Enhancement
3.4 Market Concentration Rate
3.4.1 Top 3 Drugs for Sexual Enhancement Manufacturer Market Share in 2021
3.4.2 Top 6 Drugs for Sexual Enhancement Manufacturer Market Share in 2021
3.5 Global Drugs for Sexual Enhancement Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Drugs for Sexual Enhancement Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Drugs for Sexual Enhancement Market Size by Region
4.1.1 Global Drugs for Sexual Enhancement Sales in Volume by Region (2017-2028)
4.1.2 Global Drugs for Sexual Enhancement Revenue by Region (2017-2028)
4.2 North America Drugs for Sexual Enhancement Revenue (2017-2028)
4.3 Europe Drugs for Sexual Enhancement Revenue (2017-2028)
4.4 Asia-Pacific Drugs for Sexual Enhancement Revenue (2017-2028)
4.5 South America Drugs for Sexual Enhancement Revenue (2017-2028)
4.6 Middle East and Africa Drugs for Sexual Enhancement Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Drugs for Sexual Enhancement Sales in Volume by Type (2017-2028)
5.2 Global Drugs for Sexual Enhancement Revenue by Type (2017-2028)
5.3 Global Drugs for Sexual Enhancement Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Drugs for Sexual Enhancement Sales in Volume by Application (2017-2028)
6.2 Global Drugs for Sexual Enhancement Revenue by Application (2017-2028)
6.3 Global Drugs for Sexual Enhancement Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Drugs for Sexual Enhancement Sales by Type (2017-2028)
7.2 North America Drugs for Sexual Enhancement Sales by Application (2017-2028)
7.3 North America Drugs for Sexual Enhancement Market Size by Country
7.3.1 North America Drugs for Sexual Enhancement Sales in Volume by Country (2017-2028)
7.3.2 North America Drugs for Sexual Enhancement Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Drugs for Sexual Enhancement Sales by Type (2017-2028)
8.2 Europe Drugs for Sexual Enhancement Sales by Application (2017-2028)
8.3 Europe Drugs for Sexual Enhancement Market Size by Country
8.3.1 Europe Drugs for Sexual Enhancement Sales in Volume by Country (2017-2028)
8.3.2 Europe Drugs for Sexual Enhancement Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Drugs for Sexual Enhancement Sales by Type (2017-2028)
9.2 Asia-Pacific Drugs for Sexual Enhancement Sales by Application (2017-2028)
9.3 Asia-Pacific Drugs for Sexual Enhancement Market Size by Region
9.3.1 Asia-Pacific Drugs for Sexual Enhancement Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Drugs for Sexual Enhancement Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Drugs for Sexual Enhancement Sales by Type (2017-2028)
10.2 South America Drugs for Sexual Enhancement Sales by Application (2017-2028)
10.3 South America Drugs for Sexual Enhancement Market Size by Country
10.3.1 South America Drugs for Sexual Enhancement Sales in Volume by Country (2017-2028)
10.3.2 South America Drugs for Sexual Enhancement Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Drugs for Sexual Enhancement Sales by Type (2017-2028)
11.2 Middle East & Africa Drugs for Sexual Enhancement Sales by Application (2017-2028)
11.3 Middle East & Africa Drugs for Sexual Enhancement Market Size by Country
11.3.1 Middle East & Africa Drugs for Sexual Enhancement Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Drugs for Sexual Enhancement Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Drugs for Sexual Enhancement and Key Manufacturers
12.2 Manufacturing Costs Percentage of Drugs for Sexual Enhancement
12.3 Drugs for Sexual Enhancement Production Process
12.4 Drugs for Sexual Enhancement Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Drugs for Sexual Enhancement Typical Distributors
13.3 Drugs for Sexual Enhancement Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Drugs for Sexual Enhancement Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Drugs for Sexual Enhancement Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Pfizer, Inc. Basic Information, Manufacturing Base and Competitors
Table 4. Pfizer, Inc. Major Business
Table 5. Pfizer, Inc. Drugs for Sexual Enhancement Product and Services
Table 6. Pfizer, Inc. Drugs for Sexual Enhancement Sales (Kg), Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Leading Edge Health Basic Information, Manufacturing Base and Competitors
Table 8. Leading Edge Health Major Business
Table 9. Leading Edge Health Drugs for Sexual Enhancement Product and Services
Table 10. Leading Edge Health Drugs for Sexual Enhancement Sales (Kg), Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Innovus Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 12. Innovus Pharmaceuticals Major Business
Table 13. Innovus Pharmaceuticals Drugs for Sexual Enhancement Product and Services
Table 14. Innovus Pharmaceuticals Drugs for Sexual Enhancement Sales (Kg), Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Direct Digital Basic Information, Manufacturing Base and Competitors
Table 16. Direct Digital Major Business
Table 17. Direct Digital Drugs for Sexual Enhancement Product and Services
Table 18. Direct Digital Drugs for Sexual Enhancement Sales (Kg), Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. SizeGenix Basic Information, Manufacturing Base and Competitors
Table 20. SizeGenix Major Business
Table 21. SizeGenix Drugs for Sexual Enhancement Product and Services
Table 22. SizeGenix Drugs for Sexual Enhancement Sales (Kg), Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. TEK Naturals Basic Information, Manufacturing Base and Competitors
Table 24. TEK Naturals Major Business
Table 25. TEK Naturals Drugs for Sexual Enhancement Product and Services
Table 26. TEK Naturals Drugs for Sexual Enhancement Sales (Kg), Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Vimax Basic Information, Manufacturing Base and Competitors
Table 28. Vimax Major Business
Table 29. Vimax Drugs for Sexual Enhancement Product and Services
Table 30. Vimax Drugs for Sexual Enhancement Sales (Kg), Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Xanogen Basic Information, Manufacturing Base and Competitors
Table 32. Xanogen Major Business
Table 33. Xanogen Drugs for Sexual Enhancement Product and Services
Table 34. Xanogen Drugs for Sexual Enhancement Sales (Kg), Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Vydox Basic Information, Manufacturing Base and Competitors
Table 36. Vydox Major Business
Table 37. Vydox Drugs for Sexual Enhancement Product and Services
Table 38. Vydox Drugs for Sexual Enhancement Sales (Kg), Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Global Drugs for Sexual Enhancement Sales by Manufacturer (2019, 2020, 2021, and 2022) & (Kg)
Table 40. Global Drugs for Sexual Enhancement Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 41. Market Position of Manufacturers in Drugs for Sexual Enhancement, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 42. Global Drugs for Sexual Enhancement Production Capacity by Company, (Kg): 2020 VS 2021
Table 43. Head Office and Drugs for Sexual Enhancement Production Site of Key Manufacturer
Table 44. Drugs for Sexual Enhancement New Entrant and Capacity Expansion Plans
Table 45. Drugs for Sexual Enhancement Mergers & Acquisitions in the Past Five Years
Table 46. Global Drugs for Sexual Enhancement Sales by Region (2017-2022) & (Kg)
Table 47. Global Drugs for Sexual Enhancement Sales by Region (2023-2028) & (Kg)
Table 48. Global Drugs for Sexual Enhancement Revenue by Region (2017-2022) & (USD Million)
Table 49. Global Drugs for Sexual Enhancement Revenue by Region (2023-2028) & (USD Million)
Table 50. Global Drugs for Sexual Enhancement Sales by Type (2017-2022) & (Kg)
Table 51. Global Drugs for Sexual Enhancement Sales by Type (2023-2028) & (Kg)
Table 52. Global Drugs for Sexual Enhancement Revenue by Type (2017-2022) & (USD Million)
Table 53. Global Drugs for Sexual Enhancement Revenue by Type (2023-2028) & (USD Million)
Table 54. Global Drugs for Sexual Enhancement Price by Type (2017-2022) & (US$/Kg)
Table 55. Global Drugs for Sexual Enhancement Price by Type (2023-2028) & (US$/Kg)
Table 56. Global Drugs for Sexual Enhancement Sales by Application (2017-2022) & (Kg)
Table 57. Global Drugs for Sexual Enhancement Sales by Application (2023-2028) & (Kg)
Table 58. Global Drugs for Sexual Enhancement Revenue by Application (2017-2022) & (USD Million)
Table 59. Global Drugs for Sexual Enhancement Revenue by Application (2023-2028) & (USD Million)
Table 60. Global Drugs for Sexual Enhancement Price by Application (2017-2022) & (US$/Kg)
Table 61. Global Drugs for Sexual Enhancement Price by Application (2023-2028) & (US$/Kg)
Table 62. North America Drugs for Sexual Enhancement Sales by Country (2017-2022) & (Kg)
Table 63. North America Drugs for Sexual Enhancement Sales by Country (2023-2028) & (Kg)
Table 64. North America Drugs for Sexual Enhancement Revenue by Country (2017-2022) & (USD Million)
Table 65. North America Drugs for Sexual Enhancement Revenue by Country (2023-2028) & (USD Million)
Table 66. North America Drugs for Sexual Enhancement Sales by Type (2017-2022) & (Kg)
Table 67. North America Drugs for Sexual Enhancement Sales by Type (2023-2028) & (Kg)
Table 68. North America Drugs for Sexual Enhancement Sales by Application (2017-2022) & (Kg)
Table 69. North America Drugs for Sexual Enhancement Sales by Application (2023-2028) & (Kg)
Table 70. Europe Drugs for Sexual Enhancement Sales by Country (2017-2022) & (Kg)
Table 71. Europe Drugs for Sexual Enhancement Sales by Country (2023-2028) & (Kg)
Table 72. Europe Drugs for Sexual Enhancement Revenue by Country (2017-2022) & (USD Million)
Table 73. Europe Drugs for Sexual Enhancement Revenue by Country (2023-2028) & (USD Million)
Table 74. Europe Drugs for Sexual Enhancement Sales by Type (2017-2022) & (Kg)
Table 75. Europe Drugs for Sexual Enhancement Sales by Type (2023-2028) & (Kg)
Table 76. Europe Drugs for Sexual Enhancement Sales by Application (2017-2022) & (Kg)
Table 77. Europe Drugs for Sexual Enhancement Sales by Application (2023-2028) & (Kg)
Table 78. Asia-Pacific Drugs for Sexual Enhancement Sales by Region (2017-2022) & (Kg)
Table 79. Asia-Pacific Drugs for Sexual Enhancement Sales by Region (2023-2028) & (Kg)
Table 80. Asia-Pacific Drugs for Sexual Enhancement Revenue by Region (2017-2022) & (USD Million)
Table 81. Asia-Pacific Drugs for Sexual Enhancement Revenue by Region (2023-2028) & (USD Million)
Table 82. Asia-Pacific Drugs for Sexual Enhancement Sales by Type (2017-2022) & (Kg)
Table 83. Asia-Pacific Drugs for Sexual Enhancement Sales by Type (2023-2028) & (Kg)
Table 84. Asia-Pacific Drugs for Sexual Enhancement Sales by Application (2017-2022) & (Kg)
Table 85. Asia-Pacific Drugs for Sexual Enhancement Sales by Application (2023-2028) & (Kg)
Table 86. South America Drugs for Sexual Enhancement Sales by Country (2017-2022) & (Kg)
Table 87. South America Drugs for Sexual Enhancement Sales by Country (2023-2028) & (Kg)
Table 88. South America Drugs for Sexual Enhancement Revenue by Country (2017-2022) & (USD Million)
Table 89. South America Drugs for Sexual Enhancement Revenue by Country (2023-2028) & (USD Million)
Table 90. South America Drugs for Sexual Enhancement Sales by Type (2017-2022) & (Kg)
Table 91. South America Drugs for Sexual Enhancement Sales by Type (2023-2028) & (Kg)
Table 92. South America Drugs for Sexual Enhancement Sales by Application (2017-2022) & (Kg)
Table 93. South America Drugs for Sexual Enhancement Sales by Application (2023-2028) & (Kg)
Table 94. Middle East & Africa Drugs for Sexual Enhancement Sales by Region (2017-2022) & (Kg)
Table 95. Middle East & Africa Drugs for Sexual Enhancement Sales by Region (2023-2028) & (Kg)
Table 96. Middle East & Africa Drugs for Sexual Enhancement Revenue by Region (2017-2022) & (USD Million)
Table 97. Middle East & Africa Drugs for Sexual Enhancement Revenue by Region (2023-2028) & (USD Million)
Table 98. Middle East & Africa Drugs for Sexual Enhancement Sales by Type (2017-2022) & (Kg)
Table 99. Middle East & Africa Drugs for Sexual Enhancement Sales by Type (2023-2028) & (Kg)
Table 100. Middle East & Africa Drugs for Sexual Enhancement Sales by Application (2017-2022) & (Kg)
Table 101. Middle East & Africa Drugs for Sexual Enhancement Sales by Application (2023-2028) & (Kg)
Table 102. Drugs for Sexual Enhancement Raw Material
Table 103. Key Manufacturers of Drugs for Sexual Enhancement Raw Materials
Table 104. Direct Channel Pros & Cons
Table 105. Indirect Channel Pros & Cons
Table 106. Drugs for Sexual Enhancement Typical Distributors
Table 107. Drugs for Sexual Enhancement Typical Customers
List of Figures
Figure 1. Drugs for Sexual Enhancement Picture
Figure 2. Global Drugs for Sexual Enhancement Revenue Market Share by Type in 2021
Figure 3. Male Sexual Enhancer
Figure 4. Female Sexual Enhancer
Figure 5. Global Drugs for Sexual Enhancement Revenue Market Share by Application in 2021
Figure 6. Physical Stores
Figure 7. Online Stores
Figure 8. Global Drugs for Sexual Enhancement Revenue, (USD Million) & (Kg): 2017 & 2021 & 2028
Figure 9. Global Drugs for Sexual Enhancement Revenue and Forecast (2017-2028) & (USD Million)
Figure 10. Global Drugs for Sexual Enhancement Sales (2017-2028) & (Kg)
Figure 11. Global Drugs for Sexual Enhancement Price (2017-2028) & (US$/Kg)
Figure 12. Global Drugs for Sexual Enhancement Production Capacity (2017-2028) & (Kg)
Figure 13. Global Drugs for Sexual Enhancement Production Capacity by Geographic Region: 2022 VS 2028
Figure 14. Drugs for Sexual Enhancement Market Drivers
Figure 15. Drugs for Sexual Enhancement Market Restraints
Figure 16. Drugs for Sexual Enhancement Market Trends
Figure 17. Global Drugs for Sexual Enhancement Sales Market Share by Manufacturer in 2021
Figure 18. Global Drugs for Sexual Enhancement Revenue Market Share by Manufacturer in 2021
Figure 19. Drugs for Sexual Enhancement Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 20. Top 3 Drugs for Sexual Enhancement Manufacturer (Revenue) Market Share in 2021
Figure 21. Top 6 Drugs for Sexual Enhancement Manufacturer (Revenue) Market Share in 2021
Figure 22. Global Drugs for Sexual Enhancement Sales Market Share by Region (2017-2028)
Figure 23. Global Drugs for Sexual Enhancement Revenue Market Share by Region (2017-2028)
Figure 24. North America Drugs for Sexual Enhancement Revenue (2017-2028) & (USD Million)
Figure 25. Europe Drugs for Sexual Enhancement Revenue (2017-2028) & (USD Million)
Figure 26. Asia-Pacific Drugs for Sexual Enhancement Revenue (2017-2028) & (USD Million)
Figure 27. South America Drugs for Sexual Enhancement Revenue (2017-2028) & (USD Million)
Figure 28. Middle East & Africa Drugs for Sexual Enhancement Revenue (2017-2028) & (USD Million)
Figure 29. Global Drugs for Sexual Enhancement Sales Market Share by Type (2017-2028)
Figure 30. Global Drugs for Sexual Enhancement Revenue Market Share by Type (2017-2028)
Figure 31. Global Drugs for Sexual Enhancement Price by Type (2017-2028) & (US$/Kg)
Figure 32. Global Drugs for Sexual Enhancement Sales Market Share by Application (2017-2028)
Figure 33. Global Drugs for Sexual Enhancement Revenue Market Share by Application (2017-2028)
Figure 34. Global Drugs for Sexual Enhancement Price by Application (2017-2028) & (US$/Kg)
Figure 35. North America Drugs for Sexual Enhancement Sales Market Share by Type (2017-2028)
Figure 36. North America Drugs for Sexual Enhancement Sales Market Share by Application (2017-2028)
Figure 37. North America Drugs for Sexual Enhancement Sales Market Share by Country (2017-2028)
Figure 38. North America Drugs for Sexual Enhancement Revenue Market Share by Country (2017-2028)
Figure 39. United States Drugs for Sexual Enhancement Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 40. Canada Drugs for Sexual Enhancement Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Mexico Drugs for Sexual Enhancement Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Europe Drugs for Sexual Enhancement Sales Market Share by Type (2017-2028)
Figure 43. Europe Drugs for Sexual Enhancement Sales Market Share by Application (2017-2028)
Figure 44. Europe Drugs for Sexual Enhancement Sales Market Share by Country (2017-2028)
Figure 45. Europe Drugs for Sexual Enhancement Revenue Market Share by Country (2017-2028)
Figure 46. Germany Drugs for Sexual Enhancement Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. France Drugs for Sexual Enhancement Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. United Kingdom Drugs for Sexual Enhancement Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. Russia Drugs for Sexual Enhancement Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Italy Drugs for Sexual Enhancement Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Asia-Pacific Drugs for Sexual Enhancement Sales Market Share by Region (2017-2028)
Figure 52. Asia-Pacific Drugs for Sexual Enhancement Sales Market Share by Application (2017-2028)
Figure 53. Asia-Pacific Drugs for Sexual Enhancement Sales Market Share by Region (2017-2028)
Figure 54. Asia-Pacific Drugs for Sexual Enhancement Revenue Market Share by Region (2017-2028)
Figure 55. China Drugs for Sexual Enhancement Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Japan Drugs for Sexual Enhancement Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Korea Drugs for Sexual Enhancement Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. India Drugs for Sexual Enhancement Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Southeast Asia Drugs for Sexual Enhancement Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Australia Drugs for Sexual Enhancement Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. South America Drugs for Sexual Enhancement Sales Market Share by Type (2017-2028)
Figure 62. South America Drugs for Sexual Enhancement Sales Market Share by Application (2017-2028)
Figure 63. South America Drugs for Sexual Enhancement Sales Market Share by Country (2017-2028)
Figure 64. South America Drugs for Sexual Enhancement Revenue Market Share by Country (2017-2028)
Figure 65. Brazil Drugs for Sexual Enhancement Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Argentina Drugs for Sexual Enhancement Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Middle East & Africa Drugs for Sexual Enhancement Sales Market Share by Type (2017-2028)
Figure 68. Middle East & Africa Drugs for Sexual Enhancement Sales Market Share by Application (2017-2028)
Figure 69. Middle East & Africa Drugs for Sexual Enhancement Sales Market Share by Region (2017-2028)
Figure 70. Middle East & Africa Drugs for Sexual Enhancement Revenue Market Share by Region (2017-2028)
Figure 71. Turkey Drugs for Sexual Enhancement Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Egypt Drugs for Sexual Enhancement Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Saudi Arabia Drugs for Sexual Enhancement Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. South Africa Drugs for Sexual Enhancement Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Manufacturing Cost Structure Analysis of Drugs for Sexual Enhancement in 2021
Figure 76. Manufacturing Process Analysis of Drugs for Sexual Enhancement
Figure 77. Drugs for Sexual Enhancement Industrial Chain
Figure 78. Sales Channel: Direct Channel vs Indirect Channel
Figure 79. Methodology
Figure 80. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 世界の輝度向上フィルム (BEF)市場2022年：市場規模予測（～2028年）
  • 世界の輝度向上フィルム反射型偏光板市場2022年：市場規模予測（～2028年）
  • 量子ドット強化フィルムディスプレイのグローバル市場展望 2023年-2029年：一般型、先進型
  • 世界のドライバー視覚増強システム市場2022年：市場規模予測（～2028年）
  • 世界のエンハンスメントモードGaNトランジスタ市場2022年：市場規模予測（～2028年）
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR22NO19277 )"世界の性的増強用医薬品市場2022年：市場規模予測（～2028年）" (英文：Global Drugs for Sexual Enhancement Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。